NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

Download a CSV of all Patent records.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset Search to show all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NIAID E-055-2021-0-IN-01 REPLICATION-COMPETENT ADENOVIRUS TYPE 4 SARS-COV-2 VACCINES AND THEIR USE IN National Stage 202317048886 Pending
NIAID E-037-2021-1-IN-09 Antibodies Targeting The Spike Protein Of Coronaviruses IN National Stage 202317048889 Pending
NCATS E-047-2021-0-AU-01 MULTI-CYCLC IRAK AND FLT3 INHIBITING COMPOUNDS AND USES THEREOF AU National Stage 2021410783 Pending
NCI E-056-2023-0-US-01 IDENTIFICATION OF NOVEL SEQUENCES OF THE ERVMER34-1 HUMAN ENDOGENOUS RETROVIRAL SEQUENCE FAMILY, AND MODIFICATION OF THOSE SEQUENCES FOR A MORE EFFECTIVE ANTI-CANCER VACCINE AND OTHER POTENTIAL ANTI-CANCER THERAPIES US 63/527,895 Expired
NCI E-125-2023-0-US-01 Fully Human Chimeric Antigen Receptors against CD276 for the treatment of solid tumors US 63/514,596 Expired
NIAID E-139-2006-0-US-02 Development Of Dengue Virus Vaccine Components US CON 18/355,265 12203100 Issued PDF
NCI E-067-2017-0-JP-01 METHODS OF ISOLATING NEOANTIGEN-SPECIFIC T CELL RECEPTOR SEQUENCES JP DIV 2023-117842 Issued
NIAID E-297-2016-2-IN-01 VACCINE CANDIDATES FOR HUMAN RESPIRATORY SYNCYTIAL VIRUS (RSV) HAVING ATTENUATED PHENOTYPES IN DIV 202318048655 Pending
NCATS E-047-2021-0-EA-01 MULTI-CYCLC IRAK AND FLT3 INHIBITING COMPOUNDS AND USES THEREOF EA National Stage 202391815 Pending
NIAID E-055-2021-0-EP-01 Replication-Competent Adenovirus Type 4-SARS-CoV-2 Vaccines And Their Use EP National Stage 22703165.5 Pending
NIDDK E-051-2021-0-CA-01 HETEROCYCLIC P2Y14 RECEPTOR ANTAGONISTS CA National Stage 3208662 Pending
NCI E-044-2022-0-PCT-01 KINASE INHIBITORS PCT PCT PCT/US2023/070304 Expired
NIAID E-055-2021-0-CN-01 Replication-Competent Adenovirus Type 4-SARS-CoV-2 Vaccines And Their Use CN National Stage 202280010458.8 Pending
NCI E-087-2015-1-EP-05 Methods and Compositions for Inducing an Immune Response Using Conserved Element Constructs EP DIV 23185862.2 Pending
NCI E-182-2017-0-EP-01 METHODS FOR SELECTIVELY EXPANDING CELLS EXPRESSING A TCR WITH A MURINE CONSTANT REGION EP DIV 23185846.5 Pending
NEI E-013-2021-0-EP-01 COMPOSITION AND METHOD OF PRESERVING VIABILITY OF CELL IN A LOW TEMPERATURE EP National Stage 21844141.8 Pending
NIDDK E-162-2023-0-US-01 5-HT2B SEROTONIN RECEPTOR ANTAGONISTS, PHARMACEUTICAL COMPOSITIONS THEREOF, AND METHODS OF USE THEREOF US 63/527,244 Expired
NCI E-202-2023-0-US-01 KINASE INHIBITORS US 63/527,274 Expired
NCI E-243-2020-0-AU-01 NEAR INFRARED PHOTOIMMUNOTHERAPY (NIR-PIT) COMBINATION THERAPY TO TREAT CANCER AU National Stage 2022213415 Pending
NIAID E-037-2021-1-AU-02 Antibodies Targeting The Spike Protein Of Coronaviruses AU National Stage 2022221297 Pending
NCATS E-035-2020-1-US-03 TREATING PRIMARY OR IDIOPATHIC HYPEROXALURIA WITH SMALL MOLECULE INHIBITORS OF LACTATE DEHYDROGENASE US CON 18/352,721 12233051 Issued PDF
NIDDK E-051-2021-0-US-02 HETEROCYCLIC P2Y14 RECEPTOR ANTAGONISTS US National Stage 18/272,435 Pending
NIAID E-055-2021-0-JP-01 Replication-Competent Adenovirus Type 4-SARS-CoV-2 Vaccines And Their Use JP National Stage 2023-543164 Pending
NCATS E-046-2021-0-AU-01 MULTI-CYCLIC IRAK AND FLT3 INHIBITING COMPOUNDS AND USES THEREOF AU National Stage 2021403015 Pending
NCATS E-047-2021-0-IN-01 MULTI-CYCLC IRAK AND FLT3 INHIBITING COMPOUNDS AND USES THEREOF IN National Stage 202317047196 Pending
NIDA E-023-2018-0-US-05 DREADD ACTUATORS US DIV 18/221,475 Abandoned
NCATS E-046-2021-0-EP-01 MULTI-CYCLIC IRAK AND FLT3 INHIBITING COMPOUNDS AND USES THEREOF EP National Stage 21907719.5 Pending
NCATS E-046-2021-0-EA-01 MULTI-CYCLIC IRAK AND FLT3 INHIBITING COMPOUNDS AND USES THEREOF EA National Stage 202391755 Pending
NIAID E-055-2021-0-US-02 REPLICATION-COMPETENT ADENOVIRUS TYPE 4 SARS-COV-2 VACCINES AND THEIR USE US National Stage 18/271,901 Pending
NIAID E-157-2022-0-PC-01 SARS-CoV-2 COMPOSITIONS AND METHODS FOR TREATMENT OF VIRUS-INDUCED AIRWAY FIBROSIS PCT PCT PCT/US2023/069899 Expired
NEI E-033-2021-0-US-02 EXOSOMES COMPRISING IL-35 OR IL-27 AND USES THEREOF US National Stage 18/271,583 Pending
NIAID E-202-2008-0-US-20 INHIBITORS OF THE PLASMODIAL SURFACE ANION CHANNEL AS ANTIMALARIALS US DIV 18/220,090 Pending
NHLBI E-197-2020-0-CN-01 SINGLE-CELL PROFILING OF CHROMATIN OCCUPANCY AND RNA SEQUENCING CN National Stage 202180089986.2 Abandoned
NEI E-033-2021-0-JP-01 EXOSOMES COMPRISING IL-35 OR IL-27 AND USES THEREOF JP National Stage 2023-541862 Pending
NIDCD E-173-2022-0-PC-01 IMPEDING PLATINUM-BASED CHEMOTHERAPEUTIC INDUCED OTOTOXICITY USING
A COLONY STIMULATING FACTOR 1 RECEPTOR INHIBITOR 		PCT PCT PCT/US2023/069841 Expired
NCI E-076-2022-0-PC-01 CELL-BARCODE RECORDER DEVICES AND METHODS PCT PCT PCT/US2023/069782 Expired
NHLBI E-100-2022-0-PCT-02 VERY-LONG-CHAIN POLYUNSATURATED FATTY ACIDS (VLCPUFA) FOR IMPROVING RETINA/COGNITIVE FUNCTIONS AND ATHEROSCLEROSIS PCT PCT PCT/US2023/027076 Expired
NIBIB E-139-2022-2-PC-01 METHODS AND COMPOSITIONS FOR IMPROVING WOUND HEALING PCT PCT COMB PCT/US2023/069798 Expired
NHLBI E-100-2022-0-CN-01 VERY-LONG-CHAIN POLYUNSATURATED FATTY ACIDS (VLCPUFA) FOR IMPROVING RETINA/COGNITIVE FUNCTIONS AND ATHEROSCLEROSIS CN National Stage 202380057801.9 Pending
NIBIB E-237-2020-0-JP-01 Systems and Methods for Producing Isotropic In-Plane Super-Resolution Images from Line-Scanning Confocal Microscopy JP National Stage 2023-541648 Abandoned
NEI E-033-2021-0-CA-01 EXOSOMES COMPRISING IL-35 OR IL-27 AND USES THEREOF CA National Stage 3204551 Pending
NCI E-188-2023-0-US-01 HUMANIZED 40H3 ANTIBODY US 63/525,493 Expired
NIBIB E-237-2020-0-US-02 Systems and Methods for Producing Isotropic In-Plane Super-Resolution Images from Line-Scanning Confocal Microscopy US National Stage 18/271,202 Abandoned
NLM E-107-2010-2-US-01 METHODS OF EPIGENETIC ANALYSIS US CON 18/348,096 Pending
NIBIB E-237-2020-0-CN-01 Producing Isotropic Super-Resolution Images From Line Scanning Confocal Microscopy CN National Stage 202280009117.9 Abandoned
NCI E-231-2020-0-CN-01 METHOD OF SELECTING T CELLS WITH IMPROVED ANTI-CANCER ACTIVITY CN National Stage 202180089310.3 Pending
NHLBI E-005-2021-0-CN-01 MODIFIED NK CELLS WITH REDUCED CCR5 EXPRESSION AND METHODS OF THEIR USE CN National Stage 202180089290.X Pending
NCI E-167-2017-0-US-02 CANCER TREATMENT UTILIZING PRE-EXISTING MICROBIAL IMMUNITY US DIV 18/346,680 Pending
NIA E-135-2022-1-PC-01 MONOCLONAL ANTIBODIES DIRECTED TO PHOSPHORYLATED PSD95 AND USES THEREOF PCT PCT PCT/US2023/069503 Expired
NIAID E-197-2023-0-PC-01 ANTI-SARS-COV-2 ANTIGEN BINDING POLYPEPTIDES, POLYPEPTIDE COMPLEXES AND METHODS OF USE THEREOF PCT PCT PCT/US2023/069541 Expired